Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.740
-0.035-4.52%
Volume:53.21M
Turnover:39.49M
Market Cap:6.75B
PE:32.13
High:0.775
Open:0.775
Low:0.730
Close:0.775
52wk High:1.896
52wk Low:0.730
Shares:9.12B
HK Float Shares:9.12B
Volume Ratio:3.36
T/O Rate:0.58%
Dividend:0.02
Dividend Rate:2.95%
EPS(LYR):0.023
ROE:5.57%
ROA:2.73%
PB:0.94
PE(LYR):32.13
PS:2.19

Loading ...

SIHUAN PHARM Subsidiary Xuanzhu Biopharm Seals Thailand Deal Granting Innobic Exclusive Rights to Commercialise Bireociclib Until 2036

Bulletin Express
·
Sep 03

Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets

Reuters
·
Sep 03

Sihuan Pharma Grants 116,150,000 Share Awards Under 2026 Incentive Scheme at HK$ 0.74 Each

Reuters
·
Sep 01

Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches

Simply Wall St.
·
Aug 27

Sihuan Pharmaceutical Announces HK$8.11 Million Share Buy-Back; H1 2026 Net Profit Surges 221%

Bulletin Express
·
Aug 27

SIHUAN PHARM Repurchases 10 Million Shares for HK$8.11 Million, Lifting Treasury Stock to 214 Million

Bulletin Express
·
Aug 27

Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81

Reuters
·
Aug 27

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Reuters
·
Aug 26

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion

Reuters
·
Aug 26

Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List

Reuters
·
Aug 26

SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy

Stock News
·
Aug 26

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Aug 26

Sihuan Pharmaceutical’s H1 2026 Net Profit Jumps 119% to RMB224.70 Million as Aesthetics and Innovative Drugs Offset Generic Slump

Bulletin Express
·
Aug 26

Sihuan Pharmaceutical Holdings Group H1 Net Income Attributable RMB 224.7 Million

THOMSON REUTERS
·
Aug 26

Sihuan Pharma Appoints Song Xiaomi as CFO

Reuters
·
Aug 26

Sihuan Pharma - Appoints Song Xiaomi as Chief Financial Officer Effective 26 August 2026

THOMSON REUTERS
·
Aug 26

Sihuan Pharma - Miao Guili Resigns as Executive Director, Deputy CEO, and CFO Effective 26 August 2026

THOMSON REUTERS
·
Aug 26

Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business

Stock News
·
Aug 20

Sihuan Pharmaceutical Sets 26 Aug 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express
·
Aug 14